Nautilus Biotechnology Investor Relations Material
Latest events
Q4 2023
Nautilus Biotechnology
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Nautilus Biotechnology Inc
Access all reports
Nautilus Biotechnology Inc is a development stage company that engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’s high throughput mass spectrometry platform, the Nautilus Platform, enables quantitative profiling of complex protein mixtures for an array of industrial applications.
Key slides for Nautilus Biotechnology Inc
Q4 2023
Nautilus Biotechnology Inc
Q4 2023
Nautilus Biotechnology Inc
Latest articles
Daniel Ek: Co-founder and CEO of Spotify
Explore Daniel Ek's journey from a tech-savvy teenager to the co-founder and CEO of Spotify and the most influential person in the music industry.
28 Mar 2024
Companies That Had Their IPO in 1992: A Cautiously Optimistic Market
1992 marked a relatively cool IPO landscape and stock market sentiment, in the wake of the early 90s recession.
28 Mar 2024
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States